| Date Filed | Type | Description |
| 04/18/2011 |
8-K
| Quarterly results |
| 04/15/2011 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 04/15/2011 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 04/15/2011 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 04/15/2011 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 04/15/2011 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 04/15/2011 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 04/15/2011 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 04/15/2011 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 04/15/2011 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 04/13/2011 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 04/13/2011 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities |
| 04/12/2011 |
SC TO-T/A
| Form SC TO-T - Tender offer statement by Third Party [amend] |
| 04/11/2011 |
SC 13G
| CLINICAL DATA INC reports a 7.1% stake in Clinical Data, Inc. |
| 04/08/2011 |
SC 13G/A
| CLINICAL DATA INC reports a 3.2% stake in CLINICAL DATA INC |
| 04/04/2011 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
| 04/04/2011 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/04/2011 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 03/28/2011 |
SC TO-T/A
| Form SC TO-T - Tender offer statement by Third Party [amend] |
| 03/25/2011 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 03/08/2011 |
PREM14A
| Form PREM14A - Preliminary proxy statements relating to merger or acquisition |
| 03/08/2011 |
SC 14D9
| Form SC 14D9 - Solicitation, recommendation statements |
| 03/08/2011 |
SC TO-T
| Form SC TO-T - Tender offer statement by Third Party |
| 03/04/2011 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership |
| 03/02/2011 |
BW
| The Law Offices of Vincent Wong Announce an Investigation into Possible Breaches of Fiduciary Duty by the Board of Clinical Data, Inc. in Connection with the Sale of the Company to Forest Laboratories, Inc. – CLDA |
| 03/02/2011 |
BW
| Brower Piven Announces an Investigation of the Acquisition of Clinical Data, Inc. by Forest Laboratories, Inc. |
| 03/01/2011 |
SC 13D/A
| CLINICAL DATA INC reports a 51.2% stake in CLINICAL DATA, INC. |
| 02/25/2011 |
8-K
| Form 8-K - Current report |
| 02/25/2011 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| 02/25/2011 |
BW
| Goldman Scarlato & Karon, P.C. Announces Investigation of Clinical Data, Inc. |
| 02/25/2011 |
BW
| Bull & Lifshitz, LLP Announces Investigation of the Acquisition of Clinical Data, Inc. |
| 02/23/2011 |
BW
| Clinical Data, Inc. Shareholder Investigation by Briscoe Law Firm Concerning Acquisition by Forest Laboratories, Inc. |
| 02/23/2011 |
BW
| Ryan & Maniskas, LLP Announces Investigation of Clinical Data, Inc. |
| 02/22/2011 |
BW
| The Law Office of Abe Shainberg Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Clinical Data, Inc. in Connection with the Sale of the Company to Forest Laboratories, Inc. – CLDA |
|